Long-term Survival and Value of CAR T-Cell Therapy for Pediatric Patients with Relapsed or Refractory Leukemia; Assessment of Exposure to High-Performing Schools and Risk of Adolescent Substance Use

Long-term Survival and Value of CAR T-Cell Therapy for Pediatric Patients with Relapsed or Refractory Leukemia; Assessment of Exposure to High-Performing Schools and Risk of Adolescent Substance Use

JAMA Pediatrics Editors' Summary by Dimitri Christakis, MD, MPH, Editor in Chief, and Frederick Rivara, MD, MPH, Editor of JAMA Network Open, for the December 3, 2018 issue

Jaksot(93)

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
utelias-mieli
tiedekulma-podcast
hippokrateen-vastaanotolla
docemilia
rss-lihavuudesta-podcast
filocast-filosofian-perusteet
rss-poliisin-mieli
rss-duodecim-lehti
rss-ammamafia
sotataidon-ytimessa
menologeja-tutkimusmatka-vaihdevuosiin
vinkista-vihia
radio-antro
rss-ranskaa-raakana
rss-tiedetta-vai-tarinaa
rss-ilmasto-kriisissa
rss-jyvaskylan-yliopisto
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita